Bossco(300422)
Search documents
博世科(300422) - 2016年5月31日投资者关系活动记录表
2022-12-07 00:01
Group 1: Company Overview and Market Position - Boschke is a technology-driven company specializing in high-concentration industrial wastewater treatment and environmental protection projects [2]. - The company has transitioned to a PPP (Public-Private Partnership) model, aligning with national policies promoting environmental protection [2][3]. - As of April 2016, the company has accumulated orders totaling CNY 1.667 billion, including two PPP projects [6]. Group 2: Project Management and Risks - PPP projects are characterized by significant investment amounts and long construction and operation periods, leading to inherent uncertainties [3]. - The company primarily engages in water-related PPP projects, which are considered lower risk compared to other types of PPP projects [4]. - The company has adopted two operational models for soil remediation projects: separation of design and implementation, and comprehensive service provision [5]. Group 3: Technological and Service Advantages - Boschke has developed core technologies for heavy metal pollution control and soil remediation, holding 8 national patents in related fields [5]. - The company offers a full range of services in soil remediation, including consulting, environmental assessment, design, and project management [5][7]. - The company is expanding its capabilities in environmental assessment, which is expected to enhance its market position and profitability [6][7]. Group 4: Strategic Development Plans - The company aims to expand its market in water management, including drinking water source protection and rural environmental remediation [7][8]. - There is a focus on developing projects in soil remediation, heavy metal pollution, and sludge management [8]. - The company is pursuing a non-public offering to improve its capital structure and support regional market expansion [7].
博世科(300422) - 2016年6月8日投资者关系活动记录表
2022-12-07 00:01
证券代码:300422 证券简称:博世科 广西博世科环保科技股份有限公司 投资者关系活动记录表 编号:2016-04 | --- | --- | --- | --- | |----------------|---------------------------|--------------------------------------|------------| | | | | | | | √ | 特定对象调研 □分析师会议 | | | | □ | 媒体采访 □业绩说明会 | | | 投资者关系活动 | □ 新闻发布会 □路演活动 | | | | 类别 | □ 现场参观 | | | | | □ | 其他 (请文字说明其他活动内容) | | | | 姓名 | 单位 | 职务 | | | 柴兆民 | 中国民生信托有限公司 | 创新业务部 | | | | | 总经理 | | | 郑建鑫 | 吉富创投投资股份有限公司 | 投资经理 | | 参与单位名称及 | 李思萌 | 方正证券 | 分析师 | | 人员姓名 | 王宁山 | 华夏基金 | 研究员 | | | 赵树理 | 海通证券 | 研究员 | | | 邱长伟 | ...
博世科(300422) - 2016年6月7日投资者关系活动记录表
2022-12-06 23:46
证券代码:300422 证券简称:博世科 编号:2016-03 广西博世科环保科技股份有限公司 投资者关系活动记录表 | --- | --- | --- | --- | |-----------------------|-----------------------------|------------------------------------------------------|--------| | | | | | | | √ 特定对象调研 | □分析师会议 | | | | □ 媒体采访 □业绩说明会 | | | | 投资者关系活动 | □新闻发布会 □路演活动 | | | | 类别 | □ 现场参观 | | | | | □ 其他 | (请文字说明其他活动内容) | | | | 姓名 | 单位 | 职务 | | 参与单位名称及 | 万炜 | 中信建投证券股份有限公司 | 研究员 | | | 朱瀚清 | 中信建投证券股份有限公司 | 研究员 | | 人员姓名 | | | | | | 孙春旭 | 东北证券股份有限公司 | 研究员 | | 时间 | 2016 年 6 月 7 日 | | | | 地点 | ...
博世科(300422) - 2017年5月16日投资者关系活动记录表
2022-12-06 02:34
证券代码:300422 证券简称:博世科 广西博世科环保科技股份有限公司 投资者关系活动记录表 编号:2017-01 | --- | --- | --- | --- | |----------------|------------------------|----------------------------|-------------| | | | | | | | □ 特定对象调研 | □分析师会议 | | | | □ 媒体采访 □业绩说明会 | | | | 投资者关系活动 | □新闻发布会 □路演活动 | | | | 类别 | √ 现场参观 | | | | | □ 其他 | (请文字说明其他活动内容) | | | | 姓名 | 单位 | 职务 | | 参与单位名称及 | | | 秘书长(广西 | | | | | | | 人员姓名 | | | 证券期货业 | | | 龙慧娟 | 广西上市公司协会 | 协会会长兼 | | | | | 秘书长) | | | 彭晓 | 广西上市公司协会 | 部门主任 | | | 阮靖平 | 广西上市公司协会 | 退休干部 | | | 林崇意 | 广西上市公司协会 | 退休干部 ...
博世科(300422) - 2017年9月8日投资者关系活动记录表
2022-12-05 01:58
证券代码:300422 证券简称:博世科 广西博世科环保科技股份有限公司 投资者关系活动记录表 编号:2017-02 | --- | --- | --- | --- | |----------------|-------------|---------------------------------|--------------| | | | | | | | | | | | | √ | 特定对象调研 □分析师会议 | | | | □ | 媒体采访 □业绩说明会 | | | 投资者关系活动 | □ | 新闻发布会 □路演活动 | | | 类别 | √ 现场参观 | | | | | □ | 其他 (请文字说明其他活动内容) | | | | 姓名 | 单位 | 职务 | | 参与单位名称及 | 刘毅 | 天津中财生生投资有限公司 | 分析师 | | 人员姓名 | 陈东 | 中融国际信托有限公司 | 执行董事 | | | 李传真 | 安信证券股份有限公司 | 股票研究员 | | | 曾吉庆 | 恒基伟业 | 投资经理 | | | 丛逸 | 招商证券股份有限公司 | 行业分析师 | | | 陈东飞 | 招商证券股份有限 ...
博世科(300422) - 2018年1月24日投资者关系活动记录表
2022-12-04 10:20
Financial Performance - In 2017, the company approved loans from banks totaling over 2 billion, with only 700 million utilized so far [4] - The gross profit margin for environmental equipment manufacturing exceeds 30%, while the gross profit margin for water pollution governance PPP projects is around 25% [5] - The company has approximately 350 million in new soil remediation orders as of 2017 [5] Market Outlook - The soil remediation market is expected to grow significantly, with a market space projected to reach 4.6 trillion during the "13th Five-Year Plan" period [9] - The company anticipates a doubling of order volume in professional technical services in 2018, with revenue from this segment around 40-50 million in 2017 [7] Operational Strategy - The company plans to issue convertible bonds to raise 430 million for a single project, indicating a focus on project-based funding [5] - The company aims to increase its operational revenue to approximately 200 million per year by 2019, driven by ongoing construction projects [6] Debt Management - The company has successfully recovered over 900 million in receivables in 2017, with 70% being current year receivables [8] - The company maintains a high level of accounts receivable, with strategies in place to improve collection efficiency [8] Expansion Plans - The company has established subsidiaries in 8 provinces and plans to expand to 15 provinces to tap into external markets, as the local market in Guangxi is limited [10] - The company is optimistic about the industrial wastewater treatment sector and plans to enhance R&D for equipment updates [9]
博世科(300422) - 2020年4月29日投资者关系活动记录表
2022-12-04 09:50
Group 1: Financial Performance - In 2019, water treatment business revenue was 2.53 billion, accounting for 78% of total revenue; soil remediation revenue was 356 million, accounting for 11%; professional technical service revenue was 170 million, accounting for 5%; and operational revenue was 160 million, accounting for 5% [5] - The company achieved significant cash flow improvement in 2019, primarily due to 7 PPP projects entering operation and an expected 17 projects to enter operation in 2020, leading to stable revenue inflow [5] - In Q1 2020, revenue remained stable, but net profit decreased slightly due to increased financial expenses of 14 million and delays caused by the pandemic [5][6] Group 2: Project and Order Status - The company currently has orders worth approximately 10 billion, with around 6 billion from controlling PPP projects, which will generate operational revenue during the concession period [6][7] - The company is involved in the upgrade of wastewater treatment systems for several designated hospitals in Guangxi, indicating potential growth in the medical wastewater treatment sector [6] - The company plans to gradually increase the revenue share from equipment supply (EP) to 30%, operational revenue to 30%, and reduce engineering revenue share to 30% over the next two to three years [9] Group 3: Strategic Initiatives - The company aims to enhance project construction and operational entry to mitigate the impact of Q1 construction delays [6] - It is focusing on regional expansion and business coverage by collaborating with state-owned companies to establish joint ventures [6] - The company is continuously optimizing its business model and strengthening payment collection to gradually exit underperforming PPP projects [6][8] Group 4: Competitive Positioning - The company has a strong technical team with high educational backgrounds, which has contributed to its success in obtaining significant national awards [10] - It has established multiple production bases for environmental equipment, ensuring a steady supply for its projects [10] - The company is exploring partnerships with local state-owned enterprises to leverage their investment capabilities for project development [11]
博世科(300422) - 2020年5月15日投资者关系活动记录表
2022-12-04 09:46
Financial Performance - In 2019, the company achieved operating revenue of 324,360.41 million yuan, a year-on-year increase of 19.07% [4] - The net profit attributable to ordinary shareholders was 28,244.43 million yuan, reflecting a growth of 20.30% compared to the previous year [4] - The company reported a significant improvement in operating cash flow year-on-year [4] Market Opportunities - The environmental protection industry is expected to enter a rapid development phase due to supportive government policies, with a projected market scale of 860 billion yuan for soil remediation by 2024 [5] - The waste disposal sector, particularly in garbage incineration, is anticipated to see substantial investment, with an estimated 169.93 billion yuan for new processing facilities during the 13th Five-Year Plan [5] - The market for kitchen waste treatment is expected to reach 861.14 billion yuan this year [5] Technological Advancements - The company has developed a chlorine dioxide preparation system that has achieved international advanced levels, breaking the long-standing foreign technology monopoly [9] - The technology has been industrialized since 2009, with over 40 sets of chlorine dioxide bleaching production lines provided to more than 30 enterprises in 12 countries, producing over 15 million tons of bleached pulp [9] Response to COVID-19 - The company has actively participated in upgrading wastewater treatment systems for designated hospitals during the pandemic, leading to new business opportunities in medical wastewater treatment [8] - The company has donated over a thousand tons of high-purity chlorine dioxide disinfectant to various government departments and institutions for epidemic prevention [11] Strategic Initiatives - The company is focusing on optimizing its business model and enhancing project implementation and payment collection as key priorities for the year [8] - It aims to leverage policy opportunities related to the pandemic to mitigate short-term market fluctuations and improve operational efficiency [8] Research and Development - The company holds 212 patents, including 34 invention patents, and has a patent technology conversion rate exceeding 70% [17] - It has established multiple research platforms, including a national enterprise technology center and a postdoctoral research station, to enhance its innovation capabilities [17] Competitive Landscape - The company acknowledges the competitive advantages in the wastewater treatment sector but aims to improve its net profit margin, which is currently below 10% [23] - The company is committed to continuous innovation and improving its core competitiveness to provide better returns to investors [23]
博世科(300422) - 博世科调研活动信息(更新后)
2022-12-04 09:42
博览世界 科技为先 证券代码:300422 证券简称:博世科 债券代码:123010 债券简称:博世转债 广西博世科环保科技股份有限公司 2020 年 2 月 11 日投资者关系活动记录表(更新后) | --- | --- | --- | |----------------|------------------------------|----------------------------------------------------| | | □ | 特定对象调研 √ 分析师会议 | | | □ | 媒体采访 □ 业绩说明会 | | 投资机构关系活 | □ 新闻发布会 □ 路演活动 | | | 动类别 | □ 现场参观 | | | | □ 其他 | | | 参与单位名称及 | 机构投资者 | | | 人员姓名 | | | | 时间 | 2020 年 2 月 11 日 | 16:00-17:00 | | 地点 | 电话会议 | | | 上市公司接待人 | | | | 员姓名 | 董事长助理兼投资总监:李成琪 | | | 投资者关系活动 | (一)基本情况介绍 | | | 主要内容介绍 | | 公司董事长助 ...
博世科(300422) - 博世科调研活动信息
2022-12-04 09:42
Group 1: Company Overview and Operations - The company completed the wastewater treatment project for the Yungwu Hospital in just 7 days, showcasing its efficiency and comprehensive service capabilities [4] - The investment scale for wastewater treatment systems ranges from approximately CNY 3 million to CNY 15 million, depending on the processing capacity of 100 tons/day to 1000 tons/day [4] - The company has developed integrated wastewater treatment systems and disinfection equipment, which have been successfully applied in various projects [5] Group 2: Financial Performance and Cash Flow - In 2019, the company expected significant improvement in operating cash flow, primarily due to the optimization of new orders and enhanced receivables collection [5] - The company has approximately CNY 4 billion in existing PPP orders, with construction components around CNY 1 billion [6] - The company aims to reduce its asset-liability ratio through public offerings and strategic investments, while increasing revenue from equipment sales [8] Group 3: Market Opportunities and Strategic Focus - The company is focusing on expanding its medical wastewater treatment capabilities, which are expected to grow significantly in the next one to two years [6] - The market demand for rural wastewater treatment is substantial, with the company actively involved in projects across multiple provinces [7] - The company’s automated production line for small-scale wastewater treatment equipment is expected to produce 18,000 units annually, aligning with the growing market demand [7] Group 4: Research and Development - R&D expenses accounted for approximately 60% of management costs in 2018, with an upward trend in 2019, reflecting the company's commitment to innovation [11] - The company has received national awards for its advancements in chlorine dioxide preparation technology, indicating strong technical capabilities [11] - The company’s small-scale wastewater treatment equipment has improved production efficiency by 30-40% and reduced costs by 30-40%, enhancing its competitive edge [10]